BrightSpring Health Services, Inc. Common Stock (BTSG) vs Bio-Techne Corporation (TECH)
A side-by-side comparison of BrightSpring Health Services, Inc. Common Stock and Bio-Techne Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BTSG
BrightSpring Health Services, Inc. Common Stock
$62.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
TECH
Bio-Techne Corporation
$72.58HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BTSG vs TECH
growth of $100 · dividends reinvested · last 3yBTSG +463.6% (+78.0%/yr)TECH +1.7% (+0.6%/yr)BTSG compounded faster over this window
Log scale — wide-divergence pair
BTSG TECH
BTSG vs TECH: by the numbers
- •BTSG is the larger company ($12.17B vs $11.36B market cap).
- •BTSG trades at the lower trailing earnings multiple (46.27 vs 62.57 P/E), one valuation lens rather than an overall verdict.
- •TECH converts more revenue to profit (14.97% vs 2.05% net margin).
- •BTSG grew revenue faster over the past five years (18.92% vs 5.47% CAGR).
- •TECH pays a dividend (0.55% yield), while BTSG has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BTSG | TECH |
|---|---|---|
| P/E ratio | 46.27 | 62.57 |
| Forward P/E | 34.10 | 35.48 |
| PEG ratio | 0.95 | 10.57 |
| P/S ratio | 0.85 | 9.35 |
| P/B ratio | 5.94 | 5.39 |
| EV / EBITDA | 21.92 | 32.61 |
| FCF yield | 3.31% | 2.32% |
Profitability
| Metric | BTSG | TECH |
|---|---|---|
| Gross margin | 12.38% | 65.77% |
| Operating margin | 3.33% | 20.73% |
| Net margin | 2.05% | 14.97% |
| ROE | 14.35% | 8.63% |
| ROIC | 8.97% | 7.86% |
Dividends
| Metric | BTSG | TECH |
|---|---|---|
| Dividend yield | N/A | 0.55% |
| Payout ratio | N/A | 34.48% |
Growth (annualized)
| Metric | BTSG | TECH |
|---|---|---|
| Revenue CAGR (5Y) | 18.92% | 5.47% |
| EPS CAGR (5Y) | 50.94% | 5.16% |
| FCF CAGR (5Y) | 9.24% | -3.08% |
| Total return CAGR (5Y) | N/A | -9.26% |
Frequently asked
- Which has the lower trailing P/E, BTSG or TECH?
- BTSG has the lower trailing P/E: BTSG trades at 46.27 and TECH at 62.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BTSG or TECH?
- Over the past five years, BTSG grew revenue faster — BTSG at a 18.92% CAGR versus TECH at 5.47%.
- Does BTSG or TECH pay a bigger dividend?
- TECH pays a dividend (0.55% yield), while BTSG has no payments in the available dividend history.
- Is BTSG or TECH more profitable?
- TECH runs the higher net margin — BTSG at 2.05% versus TECH at 14.97%.
Go deeper
Dig into the metrics
BrightSpring Health Services, Inc. Common Stock P/E ratioBio-Techne P/E ratioBio-Techne dividend yieldBrightSpring Health Services, Inc. Common Stock ROEBio-Techne ROEBrightSpring Health Services, Inc. Common Stock operating marginBio-Techne operating marginBrightSpring Health Services, Inc. Common Stock revenue growthBio-Techne revenue growthBrightSpring Health Services, Inc. Common Stock free cash flowBio-Techne free cash flow
BrightSpring Health Services, Inc. Common Stock & Bio-Techne appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.